Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses-Reference-Cited by-同舟云学术

Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses

Published:2015-10-04 Issue:37 Volume:6 Page:39538-39549
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ocana Alberto¹,Ethier Josee-Lyne²,Díez-González Laura¹,Corrales-Sánchez Verónica¹,Srikanthan Amirrtha²,Gascón-Escribano María J.¹,Templeton Arnoud J.³,Vera-Badillo Francisco²,Seruga Bostjan⁴,Niraula Saroj⁵,Pandiella Atanasio⁶,Amir Eitan²

Affiliation:

1. Medical Oncology Department, Albacete University Hospital and Translational Research Unit, Albacete, Spain

2. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and the Department of Medicine, University of Toronto, Toronto, Canada

3. Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, Switzerland

4. Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia

5. Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, Canada

6. Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel genomic prognostic biomarkers for dogs with cancer;Journal of Veterinary Internal Medicine;2023-10-06

2. Identificación de biomarcadores con poder pronóstico en cáncer: una perspectiva desde la ciencia de datos biomédicos y la bioinformática;Revista Abierta de Informática Aplicada;2023-09-21

3. Association between control group therapy and magnitude of clinical benefit of cancer drugs;Scientific Reports;2022-12-09

4. Changes in Companion Diagnostic Labelling: Implementation of FDA’s April 2020 Guidance for Industry for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups;Therapeutic Innovation & Regulatory Science;2022-06-10

5. A Systematic Review of Companion Diagnostic Tests by Immunohistochemistry for the Screening of Alectinib-Treated Patients in ALK-Positive Non-Small Cell Lung Cancer;Diagnostics;2022-05-23